Patrick McGann, MD, MS, Cincinnati Children’s Hospital
Articles by Patrick McGann, MD, MS, Cincinnati Children’s Hospital

What’s Next and Final Thoughts in SCD
ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Abdullah Kutlar, MD, Augusta University,Patrick McGann, MD, MS, Cincinnati Children’s Hospital ,Wally Smith, MD, Virginia Commonwealth University Experts look into what is next for sickle cell disease and provide key thoughts on the space.

Challenges in Global Access to SCD Treatments
ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Abdullah Kutlar, MD, Augusta University,Patrick McGann, MD, MS, Cincinnati Children’s Hospital ,Wally Smith, MD, Virginia Commonwealth University Key opinion leaders dive into global challenges in sickle cell disease while focusing on treatment access.

Stem Cell vs Gene Therapy Processes in SCD
ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Abdullah Kutlar, MD, Augusta University,Patrick McGann, MD, MS, Cincinnati Children’s Hospital ,Wally Smith, MD, Virginia Commonwealth University A discussion of the course of gene therapy compared with stem cell therapy.

Emerging Gene Therapy Methods in SCD
ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Abdullah Kutlar, MD, Augusta University,Patrick McGann, MD, MS, Cincinnati Children’s Hospital ,Wally Smith, MD, Virginia Commonwealth University Experts review data around emerging gene therapy approaches in sickle cell disease.

Gene Therapy Approaches in SCD
ByIfeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health,Abdullah Kutlar, MD, Augusta University,Wally Smith, MD, Virginia Commonwealth University ,Patrick McGann, MD, MS, Cincinnati Children’s Hospital An overview of gene therapy in sickle cell disease as well as clinical trials underway in the space.